Nisa Investment Advisors LLC lessened its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 31.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 14,498 shares of the technology company’s stock after selling 6,595 shares during the period. Nisa Investment Advisors LLC’s holdings in Veeva Systems were worth $4,319,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Cardinal Capital Management raised its holdings in shares of Veeva Systems by 1.0% during the third quarter. Cardinal Capital Management now owns 16,602 shares of the technology company’s stock valued at $4,946,000 after acquiring an additional 166 shares during the last quarter. Strategic Planning Group LLC increased its position in shares of Veeva Systems by 14.1% during the third quarter. Strategic Planning Group LLC now owns 25,088 shares of the technology company’s stock worth $7,474,000 after purchasing an additional 3,095 shares in the last quarter. Benjamin Edwards Inc. raised its stake in Veeva Systems by 43.8% in the 3rd quarter. Benjamin Edwards Inc. now owns 8,125 shares of the technology company’s stock valued at $2,420,000 after purchasing an additional 2,475 shares during the last quarter. Barnes Dennig Private Wealth Management LLC purchased a new position in Veeva Systems in the 3rd quarter valued at $157,000. Finally, HB Wealth Management LLC lifted its holdings in Veeva Systems by 5.2% in the 3rd quarter. HB Wealth Management LLC now owns 19,382 shares of the technology company’s stock valued at $5,774,000 after purchasing an additional 958 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Veeva Systems Price Performance
Shares of NYSE VEEV opened at $240.31 on Monday. The company has a 50 day simple moving average of $246.97 and a 200-day simple moving average of $270.97. The company has a market capitalization of $39.50 billion, a P/E ratio of 46.75, a P/E/G ratio of 1.77 and a beta of 1.07. Veeva Systems Inc. has a 1 year low of $201.54 and a 1 year high of $310.50.
Veeva Systems declared that its Board of Directors has approved a share buyback program on Monday, January 5th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the technology company to purchase up to 5.5% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board believes its stock is undervalued.
Analyst Ratings Changes
A number of equities research analysts have recently commented on the stock. Citigroup reduced their target price on shares of Veeva Systems from $349.00 to $319.00 and set a “buy” rating for the company in a research report on Monday, November 24th. Wall Street Zen cut shares of Veeva Systems from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. William Blair reiterated an “outperform” rating on shares of Veeva Systems in a report on Friday, October 17th. Weiss Ratings restated a “buy (b-)” rating on shares of Veeva Systems in a report on Monday, December 29th. Finally, KeyCorp restated a “sector weight” rating on shares of Veeva Systems in a research report on Friday, December 12th. Nineteen equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $307.42.
Read Our Latest Research Report on VEEV
Veeva Systems News Roundup
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Board-authorized buyback and new cloud launch: Veeva authorized up to US$2 billion to repurchase Class A shares and announced a new cloud offering—news that analysts and investors cited as the main reason for the earlier price jump. Why Veeva Systems (VEEV) Is Up 8.0% After US$2 Billion Buyback And New Cloud Launch
- Positive Sentiment: Large pharma customer commitment — Novo Nordisk expanded its commitment to Veeva Vault CRM for international operations, signaling strong enterprise demand and validation from a major global drugmaker. [PRNewswire] Novo Nordisk International Operations Commits to Veeva Vault CRM
- Positive Sentiment: Strategic partnership with BioMarin: A long-term deal to modernize development and commercialization workflows increases Veeva’s addressable services and tightens customer relationships—likely to support recurring revenue. Veeva and BioMarin Form Long-Term Strategic Partnership
- Positive Sentiment: Product expansion — Veeva launched an Environmental Monitoring solution to modernize manufacturing quality control, expanding its manufacturing QC suite and upsell potential within life-science customers. Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
- Positive Sentiment: Analyst sentiment improving: Truist upgraded Veeva from Hold to Buy and Stifel issued a buy—upgrades that can boost demand from institutional investors and support the valuation multiple.
- Neutral Sentiment: Investor events and visibility: Veeva is scheduled to present at the J.P. Morgan 2026 Healthcare Conference, giving management an opportunity to highlight strategy and guidance to active investors. Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
- Neutral Sentiment: Long-term performance stories and market pages (background/context) are circulating, but they’re more narrative than immediate catalysts. Here’s how much you’d have if you invested $1000 in Veeva Systems a decade ago
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Read More
- Five stocks we like better than Veeva Systems
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Huge robotics rollout underway
- Do not delete, read immediately
- Free: The Crypto Summit That Could Change Your Life
- Trump Planning to Use Public Law 63-43: Prepare Now
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
